Clinical and pathological outcomes of crescentic IgA nephropathy and Henoch-Schonlein purpura nephritis

蔡青青,解新芳,李晓萍,杨仪赫,师素芳,刘立军,陈育青,吕继成,张宏

DOI: https://doi.org/10.3760/cma.j.issn.1001-7097.2016.11.001

2016-01-01

Abstract:Objective To evaluate the clinicopathological characteristics and long-term outcomes of crescentic IgA nephropathy (crescentic IgAN) and Henoch-Schonlein purpura nephritis (crescentic HSPN).Methods Patients who were diagnosed with crescentic IgAN and crescentic HSPN through renal biopsy in Peking University First Hospital from 1998 to 2015 were enrolled and retrospectively analyzed.They were defined as ≥50％ crescentic glomeruli on kidney biopsy-one of the common causes of rapidly progressive glomerulonephritis.The primary outcome was end-stage renal disease (ESRD) and all-causes death.Multivariate COX regression was used to analyze the risk factors for prognosis.A prediction model was developed by Logistic curve.Results One hundred and forty nine patients,including 127 cases of crescentic IgAN and 22 cases of crescentic HSPN,were included.Their mean age was 36 years old and 61.7％ were men.The median proteinuria was 4.4 (2.8,6.9) g/d,serum creatinine (Scr) 294 (152,615) μmol/L and percentage of crescents was 64.3％ (55.6％ to 78.0％).There were no significant differences between crescentic IgAN and HSPN (all P ＞ 0.05) regarding above characteristics.A total of 113 patients (75.8％) entered the follow-up cohort,including 97 patients with IgAN and 16 with HSPN.After a median follow-up of 36 months (range 6 to 189),62(54.9％) patients progressed to ESRD or death.After adjusting initial Scr,renal survival showed no difference between these two groups (P=0.865).In a multivariate Cox regression model,initial Scr (HR=1.002,95％CI 1.001-1.003,P ＜ 0.001) and tubular atrophy/interstitial fibrosis ＞ 50％ (HR=2.986,95％ CI 1.046-8.530,P=0.041) were the independent risk factors for ESRD.Cumulative probability of ESRD prediction model was P=exp(-3.166 + 0.655 × Scr)/[1 + exp(-3.166 + 0.655 × Scr)] with sigmoid curve.Patients with Scr≥570 μmol/L were difficult to recover from dialysis,which was identified as a nonreturn point.This non-return point increased to 725 μmol/L when plasma exchange therapy was added.Conclusions Crescentic HSPN and IgAN have similar clinical-pathological characters and outcomes with poor prognosis.Initial Scr and tubular atrophy/interstitial fibrosis are the independent risk factors affecting prognosis.The prediction model based on Scr is established and the non-return point is identified.